4.6 Article

Hydroxyurea pharmacokinetics and precision dosing in low-resource settings

Related references

Note: Only part of the references are listed.
Article Hematology

Stroke Prevention with Hydroxyurea Enabled through Research and Education (SPHERE): a Phase 2 primary stroke prevention trial in sub-Saharan Africa

Luke R. R. Smart et al.

Summary: SPHERE is a clinical trial for sickle cell anemia in Tanzania, which incorporates TCD screening to predict stroke risk and provide relevant treatment. The study findings show a high prevalence of elevated baseline TCD velocities and splenomegaly among participants, and SPHERE aims to determine the benefits of hydroxyurea in stroke prevention and expand access to hydroxyurea treatment in Tanzania.

ACTA HAEMATOLOGICA (2023)

Article Hematology

Hydroxyurea for secondary stroke prevention in children with sickle cell anemia in Nigeria: a randomized controlled trial

Shehu U. Abdullahi et al.

Summary: This study investigated the effectiveness of fixed oral moderate-dose hydroxyurea compared with fixed oral low-dose hydroxyurea for secondary stroke prevention in children with sickle cell anemia. The results showed that there was no evidence to support the superiority of moderate-dose hydroxyurea in reducing the risk of stroke or death compared to low-dose hydroxyurea.

BLOOD (2023)

Review Hematology

Effective use of hydroxyurea for sickle cell anemia in low-resource countries

Alexandra Power-Hays et al.

CURRENT OPINION IN HEMATOLOGY (2020)

Article Medicine, General & Internal

Hydroxyurea Dose Escalation for Sickle Cell Anemia in Sub-Saharan Africa

Chandy C. John et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa

Leon Tshilolo et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Hematology

Hydroxyurea: Analytical techniques and quantitative analysis

Anu Marahatta et al.

BLOOD CELLS MOLECULES AND DISEASES (2017)

Review Medicine, General & Internal

Management of Sickle Cell Disease Summary of the 2014 Evidence-Based Report by Expert Panel Members

Barbara P. Yawn et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)